A nurse is giving discharge instructions to a patient who has been ordered Guaifenesin (Mucinex) to take BID for 3 days after discharge. What response by the patient lets her know that he understands how to take his medication?

Beclomethasone is an inhaled corticosteroid commonly used for the treatment of asthma. One of the potential side effects of inhaled corticosteroids is oral candidiasis, also known as thrush. Rinsing the mouth with water after each administration helps to reduce the risk of developing thrush by removing any residual medication from the mouth and throat.

The other options listed are not specific instructions for inhaled beclomethasone:
A. Check the pulse after medication administration: While it is important to monitor vital signs, such as pulse, in certain situations, checking the pulse after inhaled beclomethasone administration is not a specific instruction for this medication.

B. Limit caffeine intake: There is no specific need to limit caffeine intake when taking inhaled beclomethasone. However, it is generally advisable to discuss dietary considerations, including caffeine, with a healthcare provider, as individual factors and medication interactions can vary.

C. Take the medication with meals: Inhaled beclomethasone is usually taken as prescribed by the healthcare provider, and the timing of administration with meals is not typically specified.
However, it is important for the client to follow the specific instructions provided by their healthcare provider regarding the timing and frequency of inhaled medication administration.

Montelukast is a medicine used to treat and prevent asthma and allergic rhinitis. It can cause some side effects, such as stomach pain, headache, cough, or fever. However, some side effects are more serious and need to be reported to the provider.

According to the sources I found, the most serious side effect of montelukast that should be reported to the provider is depression. Depression is a mental health condition that can affect your mood, thoughts, and behavior. It can cause symptoms such as feeling sad, hopeless, or worthless; losing interest in activities you used to enjoy; having trouble sleeping or concentrating; or having thoughts of harming yourself or others.

Montelukast has been linked to neuropsychiatric events, such as agitation, aggression, sleep disturbances, suicidal thoughts and behavior (including suicide). The mechanisms underlying these events are not well understood, but they can occur at any time during treatment. Therefore, patients and caregivers should be alert for changes in behavior or new neuropsychiatric symptoms when taking montelukast. If these occur, they should discontinue montelukast and contact a healthcare provider immediately.

The other options are not listed as serious side effects of montelukast that need to be reported to the provider. Constipation, blurred vision, and palpitations are possible side effects of other medicines used to treat asthma or allergic rhinitis, such as corticosteroids, antihistamines, or beta-agonists. However, they are not specific to montelukast and may not be related to its use.